
Journal of Medicinal Chemistry p. 4195 - 4204 (1992)
Update date:2022-08-03
Topics:
Deal, Martyn J.
Hagan, Russell M.
Ireland, Simon J.
Jordan, Christopher C.
McElroy, Andrew B.
et al.
The design and synthesis of potent and selective neurokinin NK-2 receptor agonists 12 (GR64349) and 31 are described, together with structure-activity relationships for related analogues.Compound 12 (EC50 = 3.7 nM at NK-2 receptors in the rat colon; selectivity >1000- and >300-fold with respect to NK-1 and NK-3 receptors, respectively) was derived by incorporation of a Gly-Leu γ-lactam conformational constraint into the C-terminal region of the neurokinin A octapeptide analogue
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Lishui Nanming Chemical Co., Ltd(expird)
Contact:+86-0578-2134101,2697830
Address:No.19 Tongji Road Shuige Industrial zone
Suzhou Tianma Specialty Chemicals Co.,Ltd
Contact:+86-512-68090577
Address:#199, Huayuan Rd, Mudu, Suzhou, Jiangsu, CHINA
Contact:
Address:308# dongwu avenue dongxihu district wuhan city
Chengdu Green Young Biopharmaceutical INC
Contact:+86-28-85337952
Address:1-B-26,Tianhe Industry Park, No.1480 of Tianfu Road,Chengdu,P.R.China,610000
Doi:10.1002/hlca.19750580418
(1975)Doi:10.1016/S0040-4020(01)88305-8
(1992)Doi:10.1016/S0040-4039(00)74815-5
(1992)Doi:10.1016/j.molliq.2013.01.013
(2013)Doi:10.1021/jo4005684
(2013)Doi:10.1055/s-1992-26201
(1992)